• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evaluating PaySign: Insights From 9 Financial Analysts

    5/28/24 12:01:00 PM ET
    $PAYS
    EDP Services
    Technology
    Get the next $PAYS alert in real time by email

    In the last three months, 9 analysts have published ratings on PaySign (NASDAQ:PAYS), offering a diverse range of perspectives from bullish to bearish.

    The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 4 5 0 0 0
    Last 30D 0 1 0 0 0
    1M Ago 2 2 0 0 0
    2M Ago 1 0 0 0 0
    3M Ago 1 2 0 0 0

    Analysts have set 12-month price targets for PaySign, revealing an average target of $5.61, a high estimate of $7.00, and a low estimate of $4.00. This current average reflects an increase of 10.87% from the previous average price target of $5.06.

    price target chart

    Interpreting Analyst Ratings: A Closer Look

    An in-depth analysis of recent analyst actions unveils how financial experts perceive PaySign. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

    Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
    Gary Prestopino Barrington Research Maintains Outperform $7.00 $7.00
    Gary Prestopino Barrington Research Raises Outperform $7.00 $5.50
    Michael Diana Maxim Group Raises Buy $6.00 $5.50
    Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50
    Peter Heckmann DA Davidson Raises Buy $5.50 $4.50
    Peter Heckmann DA Davidson Raises Buy $4.50 $4.00
    Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50
    Peter Heckmann DA Davidson Raises Buy $4.00 $3.00
    Gary Prestopino Barrington Research Maintains Outperform $5.50 -

    Key Insights:

    • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PaySign. This information provides a snapshot of how analysts perceive the current state of the company.
    • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of PaySign compared to the broader market.
    • Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

    Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into PaySign's market standing. Stay informed and make well-considered decisions with our Ratings Table.

    Stay up to date on PaySign analyst ratings.

    If you are interested in following small-cap stock news and performance you can start by tracking it here.

    Discovering PaySign: A Closer Look

    PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized, payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

    PaySign's Economic Impact: An Analysis

    Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

    Revenue Growth: PaySign's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 30.04%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.

    Net Margin: PaySign's net margin excels beyond industry benchmarks, reaching 2.34%. This signifies efficient cost management and strong financial health.

    Return on Equity (ROE): PaySign's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.24%, the company showcases efficient use of equity capital and strong financial health.

    Return on Assets (ROA): PaySign's ROA stands out, surpassing industry averages. With an impressive ROA of 0.19%, the company demonstrates effective utilization of assets and strong financial performance.

    Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.13.

    The Basics of Analyst Ratings

    Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

    Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $PAYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PAYS

    DatePrice TargetRatingAnalyst
    12/20/2024$6.00Buy
    Lake Street
    3/30/2022$4.00Mkt Perform
    Barrington Research
    3/24/2022Buy → Neutral
    Ladenburg Thalmann
    8/20/2021$3.50Neutral → Buy
    DA Davidson
    8/19/2021Neutral → Buy
    DA Davidson
    8/12/2021$3.50 → $3.75Neutral → Buy
    Ladenburg Thalmann
    More analyst ratings

    $PAYS
    SEC Filings

    View All

    SEC Form 10-Q filed by Paysign Inc.

    10-Q - Paysign, Inc. (0001496443) (Filer)

    11/13/25 7:17:54 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    11/12/25 5:09:55 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Paysign, Inc. (0001496443) (Filer)

    9/15/25 9:01:05 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on PaySign with a new price target

    Lake Street initiated coverage of PaySign with a rating of Buy and set a new price target of $6.00

    12/20/24 8:45:02 AM ET
    $PAYS
    EDP Services
    Technology

    Barrington Research initiated coverage on PaySign with a new price target

    Barrington Research initiated coverage of PaySign with a rating of Mkt Perform and set a new price target of $4.00

    3/30/22 8:15:53 AM ET
    $PAYS
    EDP Services
    Technology

    PaySign downgraded by Ladenburg Thalmann

    Ladenburg Thalmann downgraded PaySign from Buy to Neutral

    3/24/22 7:30:30 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format. The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign's Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3. Investors interested in registering may contact their Oppe

    1/21/26 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

    Dynamic Business Rules Demonstrates the Company's Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries, today announced its annual performance analysis of pharmaceutical copay programs. The company added 55 programs during 2025, exiting the year with 131 programs – many incorporating Paysign's Dynamic Business Rules feature, which saved pharmaceutical clients more than $325 million by mitigating the harmful financial impact of copay maximizers on patients and program sponso

    1/7/26 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

    Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas. The conference is an annual invitation-only event, featuring quality public companies to interact with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats. Paysign's Chief Financial Officer, Jeff Baker,

    11/13/25 4:30:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Strobo Robert sold $109,400 worth of shares (20,000 units at $5.47), decreasing direct ownership by 6% to 327,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    12/12/25 6:08:20 PM ET
    $PAYS
    EDP Services
    Technology

    Chief Legal Officer Strobo Robert was granted 100,000 shares, increasing direct ownership by 40% to 347,290 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:46 PM ET
    $PAYS
    EDP Services
    Technology

    CEO Newcomer Mark was granted 200,000 shares, increasing direct ownership by 2% to 8,950,728 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    9/26/25 8:06:31 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Henry Daniel R bought $50,000 worth of shares (10,084 units at $4.96), increasing direct ownership by 8% to 129,884 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    6/16/25 9:00:04 PM ET
    $PAYS
    EDP Services
    Technology

    Director Henry Daniel R bought $67,716 worth of shares (19,800 units at $3.42), increasing direct ownership by 25% to 99,800 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/28/25 8:07:31 PM ET
    $PAYS
    EDP Services
    Technology

    Mina Bruce A bought $5,801 worth of shares (1,206 units at $4.81), increasing direct ownership by 0.56% to 218,500 units (SEC Form 4)

    4 - Paysign, Inc. (0001496443) (Issuer)

    5/15/24 6:19:59 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Leadership Updates

    Live Leadership Updates

    View All

    Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

    Garcia Tapped to Lead Strategy for Company's Life Science Solutions Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions. In his new role at Paysign, Mr. Garcia will implement and execute the market strategy for the company's comprehensive suite of engagement and management solutions targeting the life sciences industries. With more than two decades of executive experience in life sciences services, Mr. Garcia is a

    9/22/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Announces Acquisition of Gamma Innovation's Assets, Appoints Michael Ngo as Chief Innovation Officer

    Paysign Strengthens Leadership in Technology for Plasma and Pharmaceutical Industries  Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the assets of Gamma Innovation LLC (Gamma), significantly enhancing Paysign's capabilities in plasma donor and pharmaceutical patient engagement technologies. As part of this strategic acquisition, Paysign has appointed Michael Ngo, former Managing Member of Gamma, as its Chief Innovation Officer. "This acquisition represents an exciting milestone for Paysign as we accelerate our growth strategy and expand our

    3/25/25 8:05:00 AM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Financials

    Live finance-specific insights

    View All

    Paysign, Inc. Reports Third Quarter 2025 Financial Results

    Delivered strong performance with record revenue and improved profitability Third quarter 2025 total revenues of $21.60 million, up 41.6% from third quarter 2024 Third quarter 2025 net income of $2.22 million, up 54.2% from $1.44 million a year ago, while diluted earnings per share was $0.04 versus $0.03 for third quarter 2024 Third quarter 2025 Adjusted EBITDA of $5.04 million (23.3% of revenues), up 78.1% from $2.83 million (18.5% of revenues) a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.05 for third quarter 20241 Year-over-year plasma revenue increased 12.4% to $12.86 million; exited the quarter with 595 plasma centers, an increase of 117 plasma ce

    11/12/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports Second Quarter 2025 Financial Results

    Second quarter 2025 total revenues of $19.08 million, up 33.1% from second quarter 2024 Second quarter 2025 net income of $1.39 million, up 99.1% from $697 thousand a year ago, while diluted earnings per share was $0.02, versus $0.01 for second quarter 2024 Second quarter 2025 Adjusted EBITDA of $4.51 million, up 101.8% from $2.24 million a year ago, while diluted Adjusted EBITDA per share was $0.08 versus $0.04 for second quarter 20241 Added 123 net plasma centers during second quarter 2025, all which went live June 16. We exited the quarter with 607 centers; average monthly revenue per plasma center decreased to $7,098 compared to $7,916 for the same period last year; year-over-

    8/5/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    Paysign, Inc. Reports First Quarter 2025 Financial Results

    First quarter 2025 total revenues of $18.60 million, up 41.0% from first quarter 2024 First quarter 2025 net income of $2.59 million, or diluted earnings per share of $0.05, versus net income of $309 thousand, or diluted earnings per share of $0.01, for first quarter 2024 First quarter 2025 Adjusted EBITDA of $4.96 million, up 193.3% from $1.69 million a year ago, while diluted Adjusted EBITDA per share was $0.09 versus $0.03 for first quarter 20241 Total plasma center count increased by four net centers during first quarter 2025, exiting the quarter with 484 centers; revenue per plasma center decreased to $6,517 compared to $7,414 for the same period last year; year-over-year plasma

    5/8/25 4:05:00 PM ET
    $PAYS
    EDP Services
    Technology

    $PAYS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Paysign Inc.

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    11/14/24 7:00:30 AM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    2/12/24 12:36:58 PM ET
    $PAYS
    EDP Services
    Technology

    SEC Form SC 13G/A filed by Paysign Inc. (Amendment)

    SC 13G/A - Paysign, Inc. (0001496443) (Subject)

    1/24/24 4:05:27 PM ET
    $PAYS
    EDP Services
    Technology